Biotechnology Assets S.A. (MC:BST) — Stock Price

€0.23 EUR
▼ -0.88% today

Biotechnology Assets S.A. (MC:BST) is currently trading at €0.23 EUR, down 0.88% today. Over the past 52 weeks, shares have ranged between €0.18 and €0.46. This page tracks Biotechnology Assets S.A.'s live share price on the MC exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see BST stock market capitalisation.

Biotechnology Assets S.A. (BST) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Biotechnology Assets S.A.'s daily closing share price and trading volume on the MC exchange over the past year, giving a clear view of recent price momentum and liquidity.

Biotechnology Assets S.A. Income Statement — Revenue, Profit & Earnings by Year

Biotechnology Assets S.A.'s annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue €2.51 Million €3.91 Million €2.61 Million €3.09 Million €2.52 Million
Cost of Revenue €-138.41K €450.59K €-20.86K €49.78K €-196.76K
Gross Profit €2.65 Million €3.46 Million €2.63 Million €3.04 Million €2.72 Million
Research & Development €1.45 Million €18.22K €20.29K €47.51K
SG&A €415.34K €458.30K €605.12K €900.72K €354.94K
Total Operating Expenses €-54.89K €840.45K €4.34 Million €4.57 Million €3.90 Million
Operating Income €2.71 Million €2.65 Million €1.73 Million €-2.07 Million €-1.21 Million
EBITDA €-670.76K €5.10 Million €450.40K €-25.03K €993.11K
EBIT €-2.88 Million €2.63 Million €-1.70 Million €-2.06 Million €-1.22 Million
Interest Expense €181.27K €310.97K €345.45K €854.67K €333.36K
Income Before Tax €-3.06 Million €2.32 Million €-2.04 Million €-2.91 Million €-1.55 Million
Income Tax Expense €-139.12K €748.58K €-98.99K €103.47K €150.34K
Net Income €-2.92 Million €1.57 Million €-1.94 Million €-3.01 Million €-8.61 Million

Biotechnology Assets S.A. Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Biotechnology Assets S.A.'s financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets €14.78 Million €16.61 Million €18.47 Million €19.88 Million €20.21 Million
Total Current Assets €3.70 Million €3.76 Million €3.12 Million €4.40 Million €3.37 Million
Cash & Equivalents
Short-term Investments €46.62K €44.90K €86.70K €24.79K €25.51K
Net Receivables €3.43 Million €3.34 Million €2.21 Million €2.62 Million €2.73 Million
Inventory €-3.16 Million €18.13K
Property, Plant & Equipment
Goodwill €1.46 Million €2.10 Million €2.74 Million €3.37 Million €4.01 Million
Total Liabilities €8.17 Million €10.08 Million €14.60 Million €15.54 Million €16.37 Million
Total Current Liabilities €4.55 Million €3.61 Million €3.54 Million €3.55 Million €9.52 Million
Long-term Debt
Net Debt €4.99 Million €6.81 Million €3.03 Million €1.90 Million €2.65 Million
Total Stockholder Equity €6.61 Million €6.68 Million €4.03 Million €4.49 Million €3.99 Million
Retained Earnings €-23.57 Million €-20.65 Million €-22.22 Million €-19.86 Million €-16.85 Million

Biotechnology Assets S.A. Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Biotechnology Assets S.A. generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow €-73.85K €47.74K €-1.73 Million €-1.50 Million €8.79 Million
Capital Expenditures €720.73K €325.97K €211.52 Million €661.46K €391.53K
Free Cash Flow €-794.57K €-278.23K €-213.25 Million €-2.16 Million €8.40 Million
Investing Cash Flow €-720.73K €-325.97K €-211.52 Million €-661.46K €44.84 Million
Financing Cash Flow €637.84K €-61.01K €114.75 Million €3.28 Million €-57.84 Million
Dividends Paid €59.00 Million €961.50K
Stock-Based Compensation
Depreciation €2.20 Million €2.47 Million €214.77 Million €2.03 Million €2.21 Million
Change in Cash €-156.73K €-339.23K €-98.51 Million €1.12 Million €-4.21 Million

Biotechnology Assets S.A. Earnings History — EPS Actual vs. Analyst Estimates

Track Biotechnology Assets S.A.'s quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Earnings history is not currently available for Biotechnology Assets S.A..